Brief: Sipai Health Technology Says Bixun Pharmaceutical To Buy Shanze Technology
18/03/2026 14:03
March 18 (Reuters) - Sipai Health Technology Co, Ltd 0314.HK: BIXUN PHARMACEUTICAL TO BUY SHANZE TECHNOLOGY DEAL FOR RMB354.5 MILLION BASE CONSIDERATION Further company coverage: 0314.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sipai Health Technology
See all newsBrief: Sipai Health Technology Expects HY Net Profit Of RMB41 MLN–RMB44 MLN
Brief: Sipai Health Technology Co Says Sipai Healthcare Investment Subscribed For Wealth Management Product
Brief: Sipai Health Technology Co Says Ma Xuguang And Li Ji Each Buy 3.64 Million Shares On July 15
Brief: Sipai Health Technology's Unit Disposes 100% Stake In Sipai Zhihe Technology (Guangzhou) Co
Brief: Sipai Health Technology Says Bixun Pharmaceutical To Buy Shanze Technology